Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism

European Journal of Surgical Oncology

Volumn 39, Issue 9, 2013, Pages 951-956

  Zhang, P P ^a,b   Sun, J W ^b   Wang, X Y ^a   Liu, X M ^a   Li, K ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HUBEI CANCER HOSPITAL   (China)

Author keywords

D dimer; Non small cell lung cancer; Operable; Prognosis; Venous thromboembolism

Indexed keywords

D DIMER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VOLUME; VENOUS THROMBOEMBOLISM; WEDGE RESECTION;

D-DIMER; NON-SMALL CELL LUNG CANCER; OPERABLE; PROGNOSIS; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOEMBOLISM;

EID: 84883793453     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.06.008     Document Type: Article

References (30)

1. S.C. Koh, R. Khalil, and F.K. Lim The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer Clin Appl Thromb Hemost 12 2006 3 8
2. R.L. Bick Coagulation abnormalities in malignancy: a review Semin Thromb Hemost 18 1992 353 372
3. D. Antoniou, G. Pavlakou, and G.P. Stathopoulos Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer Lung Cancer 53 2006 205 210
4. K. Blackwell, Z. Haroon, and G. Broadwater Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status J Clin Oncol 18 2000 600 608
5. E.C. Gabazza, O. Taguchi, and T. Yamakami Evaluating prethrombotic state in lung cancer using molecular markers Chest 103 1993 196 200
6. M. Oya, Y. Akiyama, T. Okuyama, and H. Ishikawa High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer Jpn J Clin Oncol 31 2001 388 394
7. O. Taguchi, E.C. Gabazza, and H. Yasui Prognostic significance of plasma D-dimer levels in patients with lung cancer Thorax 52 1997 563 565
8. E. Unsal, F. Atalay, S. Atikcan, and A. Yilmaz Prognostic significance of hemostatic parameters in patients with lung cancer Respir Med 98 2004 93 98
9. S. Miyauchi, T. Moroyama, and S. Kyoizumi Malignant tumor cell lines produce interleukin-1-like factor In Vitro Cell Dev Biol 24 1988 753 758
10. T.P. Maduskuie Jr., K.J. McNamara, and Y. Ru Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors J Med Chem 41 1998 53 62
11. F. Gieseler, I. Luhr, and T. Kunze Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy Thromb Haemost 97 2007 1023 1030
12. D.R. Morris, Y. Ding, and T.K. Ricks Protease-Activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells Cancer Res 66 2006 307 314
13. J.H. Beer, A. Haeberli, and A. Vogt Coagulation markers predict survival in cancer patients Thromb Haemost 88 2002 745 749
14. G. Altiay, A. Ciftci, and M. Demir High plasma D-dimer level is associated with decreased survival in patients with lung cancer Clin Oncol (R Coll Radiol) 19 2007 494 498
15. K. Blackwell, H. Hurwitz, and G. Lieberman Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma Cancer 101 2004 77 82
16. G. Arpaia, M. Carpenedo, and M. Verga D-dimer before chemotherapy might predict venous thromboembolism Blood Coagul Fibrinolysis 20 2009 170 175
17. C. Ay, and I. Pabinger Tests predictive of thrombosis in cancer Thromb Res 125 Suppl. 2 2010 S12 S15
18. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850
19. F. Guadagni, P. Ferroni, and S. Basili Correlation between tumor necrosis factor-Alpha and D-dimer levels in non-small cell lung cancer patients Lung Cancer 44 2004 303 310
20. G. Palareti, B. Cosmi, and C. Legnani D-dimer testing to determine the duration of anticoagulation therapy N Engl J Med 355 2006 1780 1789
21. G.J. Gasic, G.P. Tuszynski, and E. Gorelik Interaction of the hemostatic and immune systems in the metastatic spread of tumor cells Int Rev Exp Pathol 29 1986 173 212
22. G. Buccheri, P. Torchio, and D. Ferrigno Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance Cancer 97 2003 3044 3052
23. C. Ay, D. Dunkler, and R. Pirker High D-dimer levels are associated with poor prognosis in cancer patients Haematologica 97 2012 1158 1164
24. M.T. Stender, T.B. Larsen, H.T. Sorensen, and O. Thorlacius-Ussing Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study J Thromb Haemost 10 2012 2027 2031
25. A. Alcalay, T. Wun, and V. Khatri Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival J Clin Oncol 24 2006 1112 1118
26. H.K. Chew, T. Wun, and D. Harvey Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
27. H.K. Chew, T. Wun, and D.J. Harvey Incidence of venous thromboembolism and the impact on survival in breast cancer patients J Clin Oncol 25 2007 70 76
28. W. Shi, W. Zhang, H. Sun, and Y. Shao Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-Analysis World J Surg Oncol 10 2012 265
29. F. Dentali, W. Ageno, and M.G. Pierfranceschi Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer J Thromb Haemost 9 2011 1081 1083
30. J.W. Blom, J.P. Vanderschoot, and M.J. Oostindier Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535